Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation

Recruiting Observational Study
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
5 – 70
Sex
Any
Study type
Observational
Participants needed
40 (estimated)
Sponsor
National Heart, Lung, and Blood Institute (NHLBI) · NIH
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Background: Stem cell transplants (called hematopoietic stem cell transplantation, or HSCT) are used to treat various diseases. But when the cells for this procedure are donated by someone other than the person who receives the HSCT ( allogeneic HSCT ), the recipient has an increased risk of lung inflammation and scarring. This happens when their immune cells attack healthy lung cells. In this na…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Stated willingness to comply with all study procedures and availability for the duration of the study. 2. Male or female, aged 5 - 70 years of age 3. Are to be trea…
Contacts

Gloria Y Pastor, C.R.N.P.

(301) 402-3484

pastorg@cc.nih.gov

CONTACT

Anthony F Suffredini, M.D.

(301) 496-9320

asuffredini@mail.nih.gov

CONTACT